Inflammation-Induced Mucosal KYNU Expression Identifies Human Ileal Crohn’s Disease
Open Access
- 5 May 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (5), 1360
- https://doi.org/10.3390/jcm9051360
Abstract
The widely varying therapeutic response of patients with inflammatory bowel disease (IBD) continues to raise questions regarding the unclarified heterogeneity of pathological mechanisms promoting disease progression. While biomarkers for the differentiation of Crohn’s disease (CD) versus ulcerative colitis (UC) have been suggested, specific markers for a CD subclassification in ileal CD versus colonic CD are still rare. Since an altered signature of the tryptophan metabolism is associated with chronic inflammatory disease, we sought to characterize potential biomarkers by focusing on the downstream enzymes and metabolites of kynurenine metabolism. Using immunohistochemical stainings, we analyzed and compared the mucosal tryptophan immune metabolism in bioptic samples from patients with active inflammation due to UC or CD versus healthy controls. Localization-specific quantification of immune cell infiltration, tryptophan-metabolizing enzyme expression and mucosal tryptophan downstream metabolite levels was performed. We found generally increased immune cell infiltrates in the tissue of all patients with IBD. However, in patients with CD, significant differences were found between regulatory T cell and neutrophil granulocyte infiltration in the ileum compared with the colon. Furthermore, we observed decreased kynurenine levels as well as strong kynureninase (KYNU) expression specifically in patients with ileal CD. Correspondingly, significantly elevated levels of the kynurenine metabolite 3-hydroxyanthranilic acid were detected in the ileal CD samples. Highlighting the heterogeneity of the different phenotypes of CD, we identified KYNU as a potential mucosal biomarker allowing the localization-specific differentiation of ileal CD versus colonic CD.Keywords
This publication has 37 references indexed in Scilit:
- Interrogating host immunity to predict treatment response in inflammatory bowel diseaseNature Reviews Gastroenterology & Hepatology, 2019
- Should We Divide Crohn’s Disease Into Ileum-Dominant and Isolated Colonic Diseases?Clinical Gastroenterology and Hepatology, 2019
- Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel DiseasesGastroenterology, 2017
- Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohnʼs DiseaseInflammatory Bowel Diseases, 2016
- Predictive value of epithelial gene expression profiles for response to infliximab in Crohnʼs disease‡Inflammatory Bowel Diseases, 2010
- Clinical and molecular characteristics of isolated colonic Crohnʼs diseaseInflammatory Bowel Diseases, 2008
- New serological markers in inflammatory bowel disease are associated with complicated disease behaviourGut, 2007
- IBD1 and IBD3 Determine Location of Crohn’s Disease in the Spanish PopulationInflammatory Bowel Diseases, 2004
- A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease.Inflammatory Bowel Diseases, 2003
- The molecular classification of the clinical manifestations of Crohn's diseaseGastroenterology, 2002